Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Argüelles-Arias

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Revista Espanola De Enfermedades Digestivas|September 7, 2020
Relationship between gastroenterologists and hospital pharmacists: the results of a national survey. The CONDIFA studyFederico Argüelles Arias, Javier Crespo, Miguel Ángel Calleja Hernández
Revista Espanola De Enfermedades Digestivas|March 4, 2016
Pharmaceutical costs for inflammatory bowel disease units - An issue for department heads? The GESTIONAEII surveyFederico Argüelles Arias, Manuel Barreiro-de Acosta, Joaquín Hinojosa
Revista Espanola De Enfermedades Digestivas|December 18, 2025
Gastroenterology Specialists in Private Medicine in Spain: Results of a National SEPD Survey ("PRIVIDIGEST" Survey)Andrés Sánchez-Yagüe, Joaquín Rodríguez Sánchez, Federico Argüelles-Arias
Revista Espanola De Enfermedades Digestivas|March 13, 2018
Update of the SEPD position statement on the use of biosimilars for inflammatory bowel diseaseFederico Argüelles Arias, Joaquín Hinojosa Del Val, Isabel Vera Mendoza
Revista Espanola De Enfermedades Digestivas|July 31, 2023
Safe use of proton-pump inhibitorsCarlos Martín de Argila de Prados, Julia López Cardona, Federico Argüelles-Arias
Revista Espanola De Enfermedades Digestivas|April 4, 2013
Joint position statement by “Sociedad Española de Patología Digestiva” (Spanish Society of Gastroenterology) and “Sociedad Española de Farmacología” (Spanish Society of Pharmacology) on biosimilar therapy for inflammatory bowel diseaseFederico Argüelles-Arias, Manuel Barreiro-de-Acosta, Fernando Carballo, et al.
Revista Espanola De Enfermedades Digestivas|April 28, 2020
National survey on the experiences of people with celiac disease in Spain. The CELIAC-SPAIN projectFrancesc Casellas Jordá, Federico Argüelles Arias, Rosa Burgos, et al.
Revista Espanola De Enfermedades Digestivas|December 23, 2016
A survey-based analysis on endoscopic quality indicators compliance among Spanish endoscopistsIgnacio Fernández-Urien, Federico Argüelles-Arias, Pedro A Alonso-Aguirre, et al.
Therapeutic Advances in Gastroenterology|September 1, 2023
Intravenous ustekinumab maintenance treatment in patients with loss of response to subcutaneous dosingFederico Argüelles-Arias, Teresa Valdés Delgado, Belén Maldonado Pérez, et al.
Revista Espanola De Enfermedades Digestivas|November 22, 2022
Perianal Paget's diseasePilar Navajas Hernández, Teresa Valdés Delgado, Jesús Machuca Aguado, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Revista Espanola De Enfermedades Digestivas|September 7, 2020
Relationship between gastroenterologists and hospital pharmacists: the results of a national survey. The CONDIFA studyFederico Argüelles Arias, Javier Crespo, Miguel Ángel Calleja Hernández
Revista Espanola De Enfermedades Digestivas|March 4, 2016
Pharmaceutical costs for inflammatory bowel disease units - An issue for department heads? The GESTIONAEII surveyFederico Argüelles Arias, Manuel Barreiro-de Acosta, Joaquín Hinojosa
Revista Espanola De Enfermedades Digestivas|December 18, 2025
Gastroenterology Specialists in Private Medicine in Spain: Results of a National SEPD Survey ("PRIVIDIGEST" Survey)Andrés Sánchez-Yagüe, Joaquín Rodríguez Sánchez, Federico Argüelles-Arias
Revista Espanola De Enfermedades Digestivas|March 13, 2018
Update of the SEPD position statement on the use of biosimilars for inflammatory bowel diseaseFederico Argüelles Arias, Joaquín Hinojosa Del Val, Isabel Vera Mendoza
Revista Espanola De Enfermedades Digestivas|July 31, 2023
Safe use of proton-pump inhibitorsCarlos Martín de Argila de Prados, Julia López Cardona, Federico Argüelles-Arias
Revista Espanola De Enfermedades Digestivas|April 4, 2013
Joint position statement by “Sociedad Española de Patología Digestiva” (Spanish Society of Gastroenterology) and “Sociedad Española de Farmacología” (Spanish Society of Pharmacology) on biosimilar therapy for inflammatory bowel diseaseFederico Argüelles-Arias, Manuel Barreiro-de-Acosta, Fernando Carballo, et al.
Revista Espanola De Enfermedades Digestivas|April 28, 2020
National survey on the experiences of people with celiac disease in Spain. The CELIAC-SPAIN projectFrancesc Casellas Jordá, Federico Argüelles Arias, Rosa Burgos, et al.
Revista Espanola De Enfermedades Digestivas|December 23, 2016
A survey-based analysis on endoscopic quality indicators compliance among Spanish endoscopistsIgnacio Fernández-Urien, Federico Argüelles-Arias, Pedro A Alonso-Aguirre, et al.
Therapeutic Advances in Gastroenterology|September 1, 2023
Intravenous ustekinumab maintenance treatment in patients with loss of response to subcutaneous dosingFederico Argüelles-Arias, Teresa Valdés Delgado, Belén Maldonado Pérez, et al.
Revista Espanola De Enfermedades Digestivas|November 22, 2022
Perianal Paget's diseasePilar Navajas Hernández, Teresa Valdés Delgado, Jesús Machuca Aguado, et al.
Pageof 10